Search

everythinglearnresearchcommunity

for

Search:↓

Taking too much vitamin A can cause health problems like bone pain and hair loss.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Healthy scalp reduces hair loss by managing oxidative stress.

Future clinical uses of Intense Pulsed Light (IPL) are likely to grow and become more effective with new advancements and combined treatments.

Cyclosporine may cause hair loss, so patients need monitoring.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Case reports are important in medical science for discovering drugs and identifying rare conditions, despite their limitations.

Healthy scalp leads to better hair quality and less damage.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

High TNF-α levels may increase hair loss risk after PRP therapy.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Some drugs used to treat inflammation may cause hair loss.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Blocking interferon-gamma might help treat various autoimmune diseases.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Dupilumab may cause hair loss, so patients should be monitored.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Wnt-3a helps grow more skin stem cells, which could lead to new hair loss treatments.

Prolactin may affect hair growth differently based on gender and scalp area.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.